Drug intelligence / Profile preview

oxiconazole nitrate solid lipid nanoparticles gel

Development stage
Unknown
Lead developer
Minia University
Modality
Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Topical
01

Overview

Oxiconazole nitrate solid lipid nanoparticles gel is an investigational topical antifungal formulation developed by Minia University. It consists of oxiconazole nitrate, a small molecule imidazole derivative, encapsulated within solid lipid nanoparticles (SLNs) and incorporated into a Carbopol gel base. This delivery system is specifically designed to enhance the therapeutic effectiveness of the drug by improving skin penetration and providing sustained drug release. Oxiconazole nitrate exerts its antifungal effect by inhibiting the synthesis of ergosterol, a critical component of fungal cell membranes, by targeting the enzyme lanosterol 14-alpha demethylase. In clinical assessments, this novel SLN-based gel has demonstrated superior clinical improvement, better patient satisfaction, and significantly fewer side effects compared to conventional marketed products like Tinox cream for treating various tinea infections, including tinea pedis, tinea versicolor, and tinea corporis.

Other names
oxiconazole nitrate SLNs loaded geloxiconazole nitrate SLNs geloxiconazole nitrate SLNs loaded carbopol gel
02

Targets

CYP51A1 (Sterol 14α-demethylase)

Beyond the preview

Go deeper on oxiconazole nitrate solid lipid nanoparticles gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxiconazole nitrate solid lipid nanoparticles gel.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call